Training cohort | Testing cohort | |||||
---|---|---|---|---|---|---|
Non-EGVB (N = 144) | EGVB (N = 77) | P | Non-EGVB (N = 52) | EGVB (N = 42) | P | |
Gender | 0.905 | |||||
Female | 66 (45.8%) | 30 (39.0%) | 0.401 | 23 (44.2%) | 20 (47.6%) | |
Male | 78 (54.2%) | 47 (61.0%) | 29 (55.8%) | 22 (52.4%) | ||
Age | 74.3 (7.9) | 75.4 (9.4) | 0.369 | 74.3 (7.0) | 76.6 (7.7) | 0.148 |
ALT (U/L) | 22.0 (21.1) | 27.9 (32.1) | 0.153 | 19.0 (7.9) | 22.4 (13.9) | 0.166 |
AST (U/L) | 26.7 (16.0) | 31.2 (21.6) | 0.105 | 25.6 (9.4) | 28.9 (13.9) | 0.194 |
Platelet | 192 (67.0) | 155 (53.0) | < 0.001 | 197 (63.2) | 158 (55.2) | 0.002 |
Triglyceride (mmol/L) | 1.3 (1.0) | 1.3 (1.09) | 0.846 | 1.4 (1.1) | 1.3 (1.5) | 0.731 |
Cholesterol (mmol/L) | 3.7 (0.9) | 3.6 (0.9) | 0.434 | 3.7 (1.2) | 3.7 (1.3) | 0.888 |
HDL (mmol/L) | 1.0 (0.3) | 1.1 (0.4) | 0.536 | 1.0 (0.3) | 0.9 (0.3) | 0.167 |
LDL (mmol/L) | 2.3 (0.6) | 2.2 (0.5) | 0.131 | 2.6 (1.0) | 2.3 (0.8) | 0.178 |
CRP (mg/L) | 9.9 (16.0) | 11.6 (14.7) | 0.445 | 9.9 (13.6) | 11.2 (11.3) | 0.647 |
TB (µmol/L) | 4.6 (4.3) | 5.7 (4.5) | 0.075 | 4.7 (4.5) | 5.6 (4.5) | 0.354 |
PT (s) | 11.3 (1.4) | 13.1 (2.3) | < 0.001 | 11.0 (1.1) | 12.9 (1.8) | < 0.001 |
Albumin (g/L) | 35.2 (4.7) | 33.1 (6.2) | 0.009 | 37.2 (4.8) | 32.1 (5.0) | < 0.001 |
Creatinine (µmol/L) | 71.3 (28.1) | 80.2 (33.7) | 0.048 | 69.1 (31.3) | 88.0 (36.7) | 0.01 |
INR | 1.0 (0.1) | 1.14 (0.2) | < 0.001 | 0.9 (0.1) | 1.1 (0.1) | < 0.001 |
Varices score algorithms 1 | 0.27 (0.23) | 0.57 (0.20) | < 0.001 | 0.24 (0.21) | 0.55 (0.20) | < 0.001 |
Varices score algorithms 2 | 0.8 (1.1) | 2.1 (0.8) | < 0.001 | 0.8 (0.9) | 2.0 (0.9) | < 0.001 |
MELD score | 51.0 (4.2) | 54.3 (5.2) | < 0.001 | 50.4 (4.2) | 55.0 (5.1) | < 0.001 |
Beta blocker | < 0.001 | < 0.001 | ||||
Negative | 118 (81.9%) | 43 (55.8%) | 48 (92.3%) | 24 (57.1%) | ||
Positive | 26 (18.1%) | 34 (44.2%) | 4 (7.7%) | 18 (42.9%) |